Price (delayed)
$21.375
Market cap
$831.06M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.24
Enterprise value
$780.65M
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. Longboard was formed in January 2020 by Arena to advance a portfolio of
There are no recent dividends present for LBPH.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.